Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) begins acting on appetite and blood-sugar regulation from the first dose, but most people notice meaningful changes to hunger and food intake within two to four weeks. Significant, measurable weight loss typically builds across the first one to three months, with the largest effects seen as doses are increased over time. These are prescription-only medicines: a GPhC-registered prescriber must assess whether treatment is right for you before anything is dispensed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The clearest picture of how quickly Mounjaro takes effect comes from SURMOUNT-1, the pivotal phase-3 trial published in the New England Journal of Medicine, which followed around 2,500 adults with obesity over 72 weeks. Weight loss was not front-loaded. Participants lost weight steadily across the trial period, with the rate of loss generally tracking dose increases. By around week 12, most participants had begun to see noticeable changes. The steepest part of the curve came in months three to nine, as doses moved through the mid and upper range.
At the 15 mg maintenance dose, average body-weight reduction reached approximately 20–21% by week 72. That figure is often quoted in isolation, but the shape of the curve matters as much as the endpoint: expecting dramatic results in the first fortnight sets an unfair test. The early weeks are about adjustment, not transformation.
If you want a fuller look at how the mechanism drives these results, the Mounjaro overview page covers how the dual GIP and GLP-1 receptor agonism translates into reduced appetite and slower gastric emptying.
Tirzepatide is titrated in steps (typically 2.5 mg every four weeks) so the question of how long it takes for Mounjaro to take effect cannot be separated from which dose you are taking. The first pen at 2.5 mg exists primarily so your body acclimatises to the medicine, not to produce significant weight change. Most people start to feel a genuine reduction in appetite somewhere in the 5–7.5 mg range, though some notice it earlier.
A question our prescribers hear most weeks is whether plateauing weight loss at a lower dose means the medicine has stopped working. Usually it means the current dose has reached its ceiling for that individual, and a planned increase is the appropriate next step — something a prescriber reviews at each repeat consultation.
You can read more about the practical side of timing and titration on our page on how long Mounjaro takes to work, which covers what to track between appointments.
The first pen's job is adjustment. Some people feel noticeably less hungry by day three or four; others reach week three before appetite shifts. Gastrointestinal effects (nausea, loose stools, mild reflux) are most common in the early days after each new dose and generally ease within one to two weeks, according to the NHS patient guidance on tirzepatide. Tracking these alongside weight gives a more honest picture of how your body is responding.
Practically speaking: if four full weeks at 2.5 mg have produced very little appetite change, that is expected and not a sign of failure. Weight on the scales at week four is rarely the right measure of whether the medicine is working. Our guidance on how long before Mounjaro takes effect can help you interpret what you are seeing and whether the titration schedule is on track. Our FAQs page addresses some of the most common early-weeks questions.
For those thinking about how the Mounjaro timeline compares to other licensed treatments, our weight-loss treatment overview sets out the options available in the UK.
Understanding how quickly Mounjaro takes effect also affects how people think about the commitment involved. Several months of consistent treatment are needed to see the results the trial data describes. That is worth bearing in mind when considering what Mounjaro costs privately in the UK, since effective treatment is measured in months, not a single pen.
Eli Lilly raised the UK list price significantly from September 2025, with typical private-market prices now ranging roughly £149–£375 per month depending on dose and provider. At nume, one transparent price covers the consultation, prescription, treatment and free next-working-day DPD delivery, no subscription, no auto-renewal. Every repeat is clinically re-reviewed.
If you are wondering whether Mounjaro is the right fit for your situation, or how quickly results might come relative to your starting point, the clearest next step is to speak to our prescribers through a free consultation. They review every application the same day, a real clinician, not an automated queue.
For any questions about the process before you start, our contact page has details on how to reach the clinical team directly.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.